• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    US Stocks Mixed; Dell Posts Upbeat Results

    3/1/24 9:47:39 AM ET
    $ADIL
    $BIVI
    $DELL
    $FSR
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ADIL alert in real time by email

    U.S. stocks traded mixed this morning, with the Dow Jones falling around 40 points on Friday.

    Following the market opening Friday, the Dow traded down 0.11% to 38,954.76 while the NASDAQ rose 0.11% to 16,109.20. The S&P 500 also rose, gaining, 0.04% to 5,098.24.

    Check This Out: Robinhood, Shake Shack And 2 Other Stocks Insiders Are Selling

     

    Leading and Lagging Sectors

     

    Energy shares rose by 1.1% on Friday.

    In trading on Friday, utilities shares fell by 1.1%.

     

    Top Headline

     

    Dell Technologies Inc. (NYSE:DELL) reported better-than-expected fourth-quarter financial results and increased its annual cash dividend by 20%.

     

    Equities Trading UP

     

    BioVie Inc. (NASDAQ:BIVI) shares shot up 126% to $2.80. BioVie's Ne3107 demonstrated potential improvements in motor and non-motor symptoms for Parkinson's disease patients and may be realigning physiological processes for Alzheimer's patients.

    Shares of Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) got a boost, surging 92% to $3.92. Adial Pharmaceuticals was awarded a new patent covering AD04 for the potential treatment of opioid use disorder.

    Nxu, Inc. (NASDAQ:NXU) shares were also up, gaining 39% to $1.11 after the company announced it successfully charged a Tesla Cybertruck on Feb. 26.

     

    Equities Trading DOWN

     

    GigCapital5, Inc. (NASDAQ:GIA) shares dropped 60% to $4.3999. GigCapital5 announced closing date of March 4, 2024 for business combination with QT Imaging.

    Shares of Fisker Inc. (NYSE:FSR) were down 48% to $0.38 after the company reported preliminary fourth-quarter total revenue results below estimates and said it expects to conclude there is substantial doubt about its ability to continue as a going concern when its annual financial statements are filed with the SEC.

    Scilex Holding Company (NASDAQ:SCLX) was down, falling 37% to $1.43 after reporting a $10 million bought deal offering.

    Also Check This Out: Top 3 Energy Stocks That Could Sink Your Portfolio In Q1

     

    Commodities

     

    In commodity news, oil traded up 1.7% to $79.55 while gold traded up 0.4% at $2,062.80.

    Silver traded rose 0.1% to $22.915 on Friday while copper fell 0.3% to $3.8355.

     

    Euro zone

     

    European shares were mostly higher today. The eurozone’s STOXX 600 rose 0.4%, London’s FTSE 100 rose 0.7% while Spain’s IBEX 35 Index climbed 0.8% The German DAX gained 0.4% French CAC 40 fell 0.1% while Italy’s FTSE MIB Index surged 0.9%.

    The unemployment rate in the Eurozone fell to 6.4% in January from 6.5% in the previous month, while consumer price inflation rate eased to 2.6% year-over-year in February. The HCOB Eurozone manufacturing PMI was revised up to 46.5 in February versus a preliminary level of 46.1.

    The S&P Global UK manufacturing PMI was revised higher to 47.5 in February, recording the highest level in ten months, while German manufacturing PMI rose to 42.5 in February versus a preliminary level of 42.3. French manufacturing PMI rose to 47.1 in February versus a preliminary reading of 46.8.

     

    Asia Pacific Markets

     

    Asian markets closed higher on Friday, with Japan’s Nikkei 225 gaining 1.90%, Hong Kong’s Hang Seng Index climbing 0.47%, China’s Shanghai Composite Index gaining 0.39% and India’s S&P BSE Sensex gaining 1.72%.

    Retail sales in Hong Kong fell 1.2% year-over-year in January compared to a 4.8% increase in the prior month. The HSBC Indian manufacturing PMI climbed to 56.9 in February versus a preliminary level of 56.7.

    The official NBS manufacturing PMI in China fell to 49.1 in February from 49.2 a month ago, while official NBS non-manufacturing PMI rose to 51.4 from 50.7. The au Jibun Bank Japan manufacturing PMI fell to 47.2 in February from a final reading of 48.0 in January.

     

    Economics

     

    The ISM Manufacturing index will be released at 10:00 a.m. ET.

    Now Read This: Cramer Says This AI Stock Is Just An Nvidia Play, Prefers This Stock Over Anheuser-Busch

    Get the next $ADIL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADIL
    $BIVI
    $DELL
    $FSR

    CompanyDatePrice TargetRatingAnalyst
    Dell Technologies Inc.
    $DELL
    1/15/2026$148.00Equal Weight → Overweight
    Barclays
    Dell Technologies Inc.
    $DELL
    1/13/2026$165.00Buy
    Goldman
    Dell Technologies Inc.
    $DELL
    11/17/2025Overweight → Underweight
    Morgan Stanley
    Dell Technologies Inc.
    $DELL
    10/22/2025$172.00Overweight
    Piper Sandler
    Dell Technologies Inc.
    $DELL
    10/21/2025$152.00 → $161.00Outperform
    Raymond James
    Dell Technologies Inc.
    $DELL
    9/16/2025$175.00Outperform
    Bernstein
    Dell Technologies Inc.
    $DELL
    8/29/2025Overweight → Equal Weight
    Fox Advisors
    Dell Technologies Inc.
    $DELL
    8/29/2025$125.00 → $130.00Hold
    TD Cowen
    More analyst ratings

    $ADIL
    $BIVI
    $DELL
    $FSR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President & CEO Do Cuong V bought 5,000 shares (SEC Form 4)

    4 - BIOVIE INC. (0001580149) (Issuer)

    8/13/25 4:05:17 PM ET
    $BIVI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    President Pratt Annie bought $15,246 worth of shares (61,733 units at $0.25), increasing direct ownership by 4% to 508,169 units (SEC Form 4)

    4 - Nxu, Inc. (0001722969) (Issuer)

    3/18/25 4:13:25 PM ET
    $NXU
    Construction/Ag Equipment/Trucks
    Consumer Discretionary

    Officer Shah Jaisim bought $13,800 worth of shares (30,000 units at $0.46), increasing direct ownership by 27% to 139,333 units (SEC Form 4)

    4 - Scilex Holding Co (0001820190) (Issuer)

    12/18/24 7:04:41 PM ET
    $SCLX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ADIL
    $BIVI
    $DELL
    $FSR
    SEC Filings

    View All

    SEC Form 10-Q filed by BioVie Inc.

    10-Q - BIOVIE INC. (0001580149) (Filer)

    2/6/26 5:01:18 PM ET
    $BIVI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Dell Technologies Inc.

    SCHEDULE 13G/A - Dell Technologies Inc. (0001571996) (Subject)

    2/6/26 4:40:24 PM ET
    $DELL
    Computer Manufacturing
    Technology

    Adial Pharmaceuticals Inc filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits

    8-K - ADIAL PHARMACEUTICALS, INC. (0001513525) (Filer)

    2/4/26 4:30:34 PM ET
    $ADIL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADIL
    $BIVI
    $DELL
    $FSR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Adial Applauds Congressional Directive Advancing Alternative Clinical Trial Endpoints for Substance Use Disorders, Strengthening Regulatory Path for AD04

    GLEN ALLEN, Va., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) ("Adial" or the "Company"), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today applauded the passage by Congress and signing into law by President Donald J. Trump of the Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Bill, 2026. The final legislation incorporates Senate Report 119-55, which includes a significant Congressional directive to the U.S. Food and Drug Administration (FDA) and the National Institute on Drug Abuse (NIDA) to collaborate on

    2/4/26 9:35:00 AM ET
    $ADIL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Adial Pharmaceuticals Announces Reverse Stock Split to Regain Compliance with Nasdaq's Minimum Bid Price Requirement

    GLEN ALLEN, Va., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) ("Adial" or the "Company"), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today announced that it will effect a 1-for-25 reverse stock split (the "Reverse Split") of its common stock, par value $0.001 per share ("Common Stock"), that will become effective on February 5, 2026 at 11:59 p.m. Eastern Time (the "Effective Time"). Adial's Common Stock will continue to trade on the Nasdaq Capital Market ("Nasdaq") under the symbol "ADIL" and will begin trading on a split-adjusted basis when the Nasdaq opens o

    2/3/26 4:05:00 PM ET
    $ADIL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Scilex Holding Company Announces $20 Million Strategic Investment in Quantum Scan Holdings, Inc., Targeting Trillion-Dollar Preventive Diagnosis and Prognosis Markets

    PALO ALTO, Calif., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company ("Scilex" or the "Company") (NASDAQ:SCLX), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain and neurodegenerative and cardiometabolic disease, today announced that it has made a $20 million strategic investment in Quantum Scan Holdings, Inc. ("Quantum Scan"), a breakthrough medical technology company, targeting trillion-dollar market of preventive diagnosis and prognosis of human diseases and illness. The investment is intended to support Quantum Scan's ongoing efforts to identify, develop,

    1/30/26 9:00:00 AM ET
    $DVLT
    $SCLX
    Semiconductors
    Technology
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ADIL
    $BIVI
    $DELL
    $FSR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Dell upgraded by Barclays with a new price target

    Barclays upgraded Dell from Equal Weight to Overweight and set a new price target of $148.00

    1/15/26 8:27:45 AM ET
    $DELL
    Computer Manufacturing
    Technology

    Goldman resumed coverage on Dell with a new price target

    Goldman resumed coverage of Dell with a rating of Buy and set a new price target of $165.00

    1/13/26 9:15:50 AM ET
    $DELL
    Computer Manufacturing
    Technology

    Dell downgraded by Morgan Stanley

    Morgan Stanley downgraded Dell from Overweight to Underweight

    11/17/25 9:39:59 AM ET
    $DELL
    Computer Manufacturing
    Technology

    $ADIL
    $BIVI
    $DELL
    $FSR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Accounting Officer Sharp Richard Troy covered exercise/tax liability with 231 units of Class C Common Stock, decreasing direct ownership by 3% to 7,595 units (SEC Form 4)

    4 - Dell Technologies Inc. (0001571996) (Issuer)

    1/16/26 4:07:52 PM ET
    $DELL
    Computer Manufacturing
    Technology

    Large owner Scilex Holding Co sold $13,215,896 worth of shares (15,965,541 units at $0.83), decreasing direct ownership by 7% to 213,766,229 units (SEC Form 4)

    4 - Scilex Holding Co (0001820190) (Reporting)

    1/14/26 8:04:02 PM ET
    $SCLX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 4 filed by Chief Medical Officer Palumbo Joseph M

    4 - BIOVIE INC. (0001580149) (Issuer)

    1/9/26 5:03:29 PM ET
    $BIVI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADIL
    $BIVI
    $DELL
    $FSR
    Leadership Updates

    Live Leadership Updates

    View All

    Scilex Holding Company Appoints Kasowitz LLP as Litigation and Intellectual Property Counsel

    PALO ALTO, Calif., Jan. 02, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company ("Scilex" or the "Company") (NASDAQ:SCLX), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain and neurodegenerative and cardiometabolic disease, announced that it has appointed Kasowitz LLP and its founding partner Marc Kasowitz as the Company's litigation and intellectual property counsel. Kasowitz LLP will advise Scilex on complex commercial litigation, patent litigation, intellectual property enforcement and defense, licensing matters, and strategic intellectual property governance as the C

    1/2/26 9:00:00 AM ET
    $SCLX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Merlin Expands Executive Team Ahead of Public Listing

    Leslie Ravestein joins as Chief Legal Officer, David Lasater as Chief People Officer, and Pablo Gonzalez as Senior Vice President of Engineering Merlin Labs, Inc. ("Merlin"), a leading developer of assured, autonomous flight technology for defense customers, today announced key additions to its executive leadership team to optimize the organization in advance of its public listing via a Business Combination with Inflection Point Acquisition Corp. IV (NASDAQ:BACQ). The hires include two C-Suite additions, Leslie Ravestein as Chief Legal Officer and David Lasater as Chief People Officer, to strengthen corporate governance, drive operational excellence, and elevate talent strategy. Merlin al

    11/19/25 9:00:00 AM ET
    $AKAM
    $BACQ
    $DELL
    Real Estate
    Computer Manufacturing
    Technology
    Computer Software: Prepackaged Software

    BioVie Unveils Corporate Advisory Board Featuring Neuralink Co-Founder, Former Executives from Mastercard and Apple, and High-Impact Industry Leaders to Advance BioVie Mission and Growth

    The seven-member Board includes Cedars-Sinai brain health leader Dr. Zaldy Tan, Parkwood marketing powerhouse Justina Omokhua, and Neuralink visionary Tim Gardner Each Board member brings deep personal conviction and cross-sector expertise to unlock value and reshape care in Alzheimer's, Parkinson's and other neuroinflammatory disorders CARSON CITY, Nev., May 05, 2025 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ:BIVI) ("BioVie" or the "Company"), a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver disease, today announced the formation of its Corporate Advisory Board – a coalition of seven powerhous

    5/5/25 8:00:00 AM ET
    $BIVI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADIL
    $BIVI
    $DELL
    $FSR
    Financials

    Live finance-specific insights

    View All

    Datavault AI Inc. (NASDAQ: DVLT) Announces a Distribution Date of Dec. 24, 2025, for the Dream Bowl Meme Coin Tokens to All Eligible Record Equity Holders of Datavault AI and Holders of Common Stock of Scilex Holding Company

    PHILADELPHIA, Dec. 11, 2025 (GLOBE NEWSWIRE) -- via IBN-- Datavault AI Inc. (NASDAQ:DVLT) ("Datavault AI" or the "Company"), a leader in data monetization, credentialing, and digital engagement technologies, today announced that its board of directors (the "Datavault Board") has set Dec. 24, 2025, as the distribution date for the Dream Bowl 2026 Meme Coin token (the "Meme Coin") to all eligible record equityholders of Datavault AI.  Dec. 24, 2025, will also be the distribution date for Datavault AI's voluntary distribution of Meme Coins to record holders of common stock of Scilex Holding Company (NASDAQ:SCLX), which is being made as a token of Datavault AI's appreciation for Scilex's relat

    12/11/25 4:05:00 PM ET
    $DVLT
    $SCLX
    Semiconductors
    Technology
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Dell Technologies Declares Quarterly Cash Dividend

    Dell Technologies (NYSE:DELL) announces that its board of directors has declared a quarterly cash dividend of $0.525 per common share, which will be payable on Jan. 30, 2026 to shareholders of record as of Jan. 20, 2026. Dell increased its annual cash dividend by 18% to $2.10 per common share following board approval in February of this year. About Dell Technologies Dell Technologies (NYSE:DELL) helps organizations and individuals build their digital future and transform how they work, live and play. The company provides customers with the industry's broadest and most innovative technology and services portfolio for the AI era. Copyright © 2025 Dell Inc. or its subsidiaries. All Rights

    12/4/25 4:55:00 PM ET
    $DELL
    Computer Manufacturing
    Technology

    Dell Technologies Delivers Third Quarter Fiscal 2026 Financial Results

    Dell Technologies (NYSE:DELL) announces financial results for its fiscal 2026 third quarter and provides guidance for its fiscal 2026 fourth quarter and full year. The company also names David Kennedy its chief financial officer on a permanent basis. Third-Quarter Summary Record third-quarter revenue of $27.0 billion, up 11% year over year Diluted earnings per share (EPS) of $2.28, up 39% year over year, and record third-quarter non-GAAP diluted EPS of $2.59, up 17% Cash flow from operations of $1.2 billion "In the third quarter we delivered record Q3 revenue of $27 billion, record Q3 profitability, strong cash generation and above-trend capital return of $1.6 billion," said David

    11/25/25 4:05:00 PM ET
    $DELL
    Computer Manufacturing
    Technology

    $ADIL
    $BIVI
    $DELL
    $FSR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Adial Pharmaceuticals Inc

    SC 13G/A - ADIAL PHARMACEUTICALS, INC. (0001513525) (Subject)

    11/14/24 3:44:01 PM ET
    $ADIL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Dell Technologies Inc.

    SC 13G/A - Dell Technologies Inc. (0001571996) (Subject)

    11/12/24 4:40:00 PM ET
    $DELL
    Computer Manufacturing
    Technology

    Amendment: SEC Form SC 13G/A filed by Dell Technologies Inc.

    SC 13G/A - Dell Technologies Inc. (0001571996) (Subject)

    11/12/24 2:29:00 PM ET
    $DELL
    Computer Manufacturing
    Technology